SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-18-001767
Filing Date
2018-02-06
Accepted
2018-02-06 09:15:46
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dffn20180205_s3.htm S-3 556559
2 EXHIBIT 5.1 ex_104344.htm EX-5.1 17440
3 EXHIBIT 23.1 ex_104355.htm EX-23.1 3203
4 ex_104344.jpg GRAPHIC 2780
5 dffn20180205_s3.jpg GRAPHIC 10123
  Complete submission text file 0001437749-18-001767.txt   596505
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222879 | Film No.: 18576348
SIC: 2834 Pharmaceutical Preparations